Follow The Filings

HSCS HeartSciences

HeartSciences earnings company data as of 7:55 PM ET 9/21

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 14 Sep EPS -0.72 — —
Rev — — —

Insider trades

Open-market buys and sales by HSCS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HSCS insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
424B5 PROSPECTUS SUPPLEMENT
DEFA14A CURRENT REPORT
8-K 7.01,9.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A CURRENT REPORT
8-K 1.01,2.03,9.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 7.01,8.01,9.01
DEFA14A CURRENT REPORT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 2.02,9.01
DEFA14A CURRENT REPORT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
10-Q FORM 10-Q
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
DEFA14A DEFINITIVE ADDITIONAL MATERIALS

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.